Your browser doesn't support javascript.
loading
Growing Glycans in Rosetta: Accurate de novo glycan modeling, density fitting, and rational sequon design.
Adolf-Bryfogle, Jared; Labonte, Jason W; Kraft, John C; Shapovalov, Maxim; Raemisch, Sebastian; Lütteke, Thomas; DiMaio, Frank; Bahl, Christopher D; Pallesen, Jesper; King, Neil P; Gray, Jeffrey J; Kulp, Daniel W; Schief, William R.
Affiliation
  • Adolf-Bryfogle J; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Labonte JW; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.
  • Kraft JC; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, California, United States of America.
  • Shapovalov M; Institute for Protein Innovation, Boston, Massachusetts, United States of America.
  • Raemisch S; Division of Hematology-Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Lütteke T; Department of Chemistry & Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • DiMaio F; Department of Biochemistry, University of Washington, Seattle, Washington, United States of America.
  • Bahl CD; Institute for Protein Design, University of Washington, Seattle, Washington, United States of America.
  • Pallesen J; Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America.
  • King NP; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Gray JJ; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.
  • Kulp DW; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, California, United States of America.
  • Schief WR; Institute of Veterinary Physiology and Biochemistry, Justus-Liebig-University Giessen, Giessen, Germany.
PLoS Comput Biol ; 20(6): e1011895, 2024 Jun 24.
Article in En | MEDLINE | ID: mdl-38913746
ABSTRACT
Carbohydrates and glycoproteins modulate key biological functions. However, experimental structure determination of sugar polymers is notoriously difficult. Computational approaches can aid in carbohydrate structure prediction, structure determination, and design. In this work, we developed a glycan-modeling algorithm, GlycanTreeModeler, that computationally builds glycans layer-by-layer, using adaptive kernel density estimates (KDE) of common glycan conformations derived from data in the Protein Data Bank (PDB) and from quantum mechanics (QM) calculations. GlycanTreeModeler was benchmarked on a test set of glycan structures of varying lengths, or "trees". Structures predicted by GlycanTreeModeler agreed with native structures at high accuracy for both de novo modeling and experimental density-guided building. We employed these tools to design de novo glycan trees into a protein nanoparticle vaccine to shield regions of the scaffold from antibody recognition, and experimentally verified shielding. This work will inform glycoprotein model prediction, glycan masking, and further aid computational methods in experimental structure determination and refinement.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: PLoS Comput Biol Journal subject: BIOLOGIA / INFORMATICA MEDICA Year: 2024 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: PLoS Comput Biol Journal subject: BIOLOGIA / INFORMATICA MEDICA Year: 2024 Document type: Article Affiliation country: United States
...